Efficacy and safety of tripterygium wilfordii Hook F plus TNF inhibitor for active rheumatoid arthritis: A multicentre, randomized, double-blind, triple-dummy controlled trial.
暂无分享,去创建一个
P. Lipsky | Lijun Wu | Liangjing Lu | Liyun Zhang | L. Dai | X. Zuo | Z. Shuai | Wei Wei | Huaxia Yang | Xiaomei Li | N. Yang | Jiangyun Peng | Huan-Wei Chen | Xuan Zhang | Ying Jiang | Hongbin Li | Wei Ji | Zhenbin Li | Yu-dong Liu
[1] Xuan Zhang,et al. A high-fiber diet synergizes with Prevotella copri and exacerbates rheumatoid arthritis , 2022, Cellular & Molecular Immunology.
[2] Wei Gao,et al. Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives , 2021, Theranostics.
[3] H. Matsuno,et al. Comparison of the efficacy and safety of LBAL, a candidate adalimumab biosimilar, and adalimumab reference product in patients with active rheumatoid arthritis inadequately responding to methotrexate: a 52-week phase III randomised study. , 2020, Clinical and experimental rheumatology.
[4] Zhuoli Zhang,et al. Efficacy of methotrexate and etanercept biosimilar rhTNFR:Fc in Chinese patients with active rheumatoid arthritis: A controlled, randomized and multicenter study , 2020, Scientific Reports.
[5] Tsutomu Takeuchi,et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update , 2020, Annals of the Rheumatic Diseases.
[6] J. Smolen,et al. Diagnosis and Management of Rheumatoid Arthritis: A Review , 2018, JAMA.
[7] P. Lipsky,et al. Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study , 2018, Arthritis Research & Therapy.
[8] Q. Wang,et al. Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis. , 2018, Clinical and experimental rheumatology.
[9] J. Zhao,et al. A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F , 2018, Front. Pharmacol..
[10] W. Dixon,et al. Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project , 2017, Annals of the rheumatic diseases.
[11] R. Moots,et al. Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial , 2017, The Lancet.
[12] I. McInnes,et al. Rheumatoid arthritis , 2016, The Lancet.
[13] P. Santos-Moreno,et al. Direct Comparative Effectiveness Among 3 Anti–Tumor Necrosis Factor Biologics in a Real-Life Cohort of Patients With Rheumatoid Arthritis , 2016, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[14] Huijue Jia,et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment , 2015, Nature Medicine.
[15] Lifei Peng,et al. Modulation of IL-37 expression by triptolide and triptonide in THP-1 cells , 2014, Cellular and Molecular Immunology.
[16] P. Lipsky,et al. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial , 2014, Annals of the rheumatic diseases.
[17] Z. Yin,et al. [Etanercept combined with Tripterygium wilfordii polyglycoside for treatment of rheumatoid arthritis in the elderly: a clinical study]. , 2014, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
[18] Yanqiong Zhang,et al. Triptolide Prevents Bone Destruction in the Collagen-Induced Arthritis Model of Rheumatoid Arthritis by Targeting RANKL/RANK/OPG Signal Pathway , 2013, Evidence-based complementary and alternative medicine : eCAM.
[19] Fengchun Zhang,et al. The Safety and Effectiveness of a Chloroform/Methanol Extract of Tripterygium wilfordii Hook F (T2) Plus Methotrexate in Treating Rheumatoid Arthritis , 2010, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[20] P. Lipsky,et al. Comparison of Tripterygium wilfordii Hook F Versus Sulfasalazine in the Treatment of Rheumatoid Arthritis , 2009, Annals of Internal Medicine.
[21] Changyou Wu,et al. Triptolide Inhibits the Differentiation of Th17 cells and Suppresses Collagen‐induced Arthritis , 2008, Scandinavian journal of immunology.
[22] P. Lipsky,et al. Effective therapy for nephritis in (NZB x NZW)F1 mice with triptolide and tripdiolide, the principal active components of the Chinese herbal remedy Tripterygium wilfordii Hook F. , 2008, Arthritis and rheumatism.
[23] P. Lipsky,et al. Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription. , 2004, Arthritis and rheumatism.
[24] P. Lipsky,et al. Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. , 2002, Arthritis and rheumatism.
[25] P. Lipsky,et al. A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis. , 2001, The Journal of rheumatology.
[26] Richard W. Martin,et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. , 2000, The New England journal of medicine.
[27] C. Bao,et al. A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China , 2008, Rheumatology International.